Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.51 |
| ▸ | RARB | P10826 | 5/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MITF | O75030 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.41 |
| ▸ | RARA | P10276 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25427287 | 1.00 | L3MBTL1 (0.51) | L3MBTL1RARBMMP2PLA2G4BKDM4E | |
| SCHEMBL25623345 | 1.00 | L3MBTL1 (0.51) | L3MBTL1RARBMMP2PLA2G4BKDM4E | |
| SCHEMBL25623340 | 1.00 | L3MBTL1 (0.51) | L3MBTL1RARBMMP2PLA2G4BKDM4E | |
| SCHEMBL22895274 | 0.92 | RARB (0.53) | L3MBTL1RARBPLA2G4BKDM4EALDH1A1 | |
| SCHEMBL25897953 | 0.88 | RARB (0.45) | L3MBTL1RARBKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL25898026 | 0.88 | RARB (0.45) | L3MBTL1RARBKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL25894407 | 0.82 | RARB (0.45) | L3MBTL1RARBKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL21125363 | 0.81 | L3MBTL1 (0.46) | L3MBTL1RARBKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL25493962 | 0.81 | L3MBTL1 (0.46) | L3MBTL1RARBKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL25890923 | 0.81 | RARB (0.39) | L3MBTL1RARBMMP2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023012437-A1 | ANTIBODY-DRUG CONJUGATES | MC SAF (FR) | 2023-02-09 | — | — | WO | disclosed |
| US-10953098-B2 | Chemical structures for localized delivery of therapeutic agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-03-23 | — | — | US | disclosed |
| US-20190111140-A1 | CHEMICAL STRUCTURES FOR LOCALIZED DELIVERY OF THERAPEUTIC AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-04-18 | — | — | US | disclosed |
| US-20160120987-A1 | CHEMICAL STRUCTURES FOR LOCALIZED DELIVERY OF THERAPEUTIC AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190111140-A1 | CHEMICAL STRUCTURES FOR LOCALIZED DELIVERY OF THERAPEUTIC AGENTS | FABP1, EPCAM, CD44 | L3MBTL1 986/4885RARB 966/4885MMP2 659/4885 |
| US-10953098-B2 | Chemical structures for localized delivery of therapeutic agents | FABP1, EPCAM, CD44 | L3MBTL1 986/4885RARB 966/4885MMP2 659/4885 |
| US-20160120987-A1 | CHEMICAL STRUCTURES FOR LOCALIZED DELIVERY OF THERAPEUTIC AGENTS | FABP1, EPCAM, CD44 | L3MBTL1 986/4885RARB 966/4885MMP2 659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.